Adjunctive use of nilotinib in patient with imatinib resistant or intolerant chronic myeloid leukaemia (CML) undergoing a reduced intensity conditioned allogeneic transplant

Mise à jour : Il y a 4 ans
Référence : ISRCTN12974558